{"version":"1.0","provider_name":"Pharma Trend","provider_url":"https:\/\/pharma-trend.com\/en","author_name":"Business Wire","author_url":"https:\/\/pharma-trend.com\/en\/author\/business\/","title":"neuro42 Licenses Robot from Johns Hopkins University - Pharma Trend","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"Uh9NdKsLrg\"><a href=\"https:\/\/pharma-trend.com\/en\/neuro42-licenses-robot-from-johns-hopkins-university\/\">neuro42 Licenses Robot from Johns Hopkins University<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/pharma-trend.com\/en\/neuro42-licenses-robot-from-johns-hopkins-university\/embed\/#?secret=Uh9NdKsLrg\" width=\"600\" height=\"338\" title=\"&#8220;neuro42 Licenses Robot from Johns Hopkins University&#8221; &#8212; Pharma Trend\" data-secret=\"Uh9NdKsLrg\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/pharma-trend.com\/en\/wp-includes\/js\/wp-embed.min.js\n<\/script>\n","description":"SAN FRANCISCO&#8211;(BUSINESS WIRE)&#8211;neuro42, Inc. (\u201cneuro42\u201d or the \u201cCompany\u201d), a medical imaging, robotics, and AI technology company, today announced an exclusive licensing agreement with Johns Hopkins University (\u201cJohns Hopkins\u201d) for their MR compatible robot for head, neck and spine applications, with additional non-exclusive licenses for related technologies and patents. Developed by Dr. Dan Stoianovici, director of ... [Read more...]","thumbnail_url":"https:\/\/mms.businesswire.com\/media\/20220518006046\/en\/1460484\/21\/2-1-Dark_BG.jpg"}